High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand

Objectives: To investigate the seroprevalence of respiratory syncytial virus (RSV) infections in young children, the correlation between RSV antibody levels in maternal and cord serum, and to provide evidence of RSV reinfection in Thai children after primary infections. Methods: Serum samples were c...

Full description

Bibliographic Details
Main Authors: Siripat Pasittungkul, Ilada Thongpan, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Sirapa Klinfueng, Nungruthai Suntronwong, Nasamon Wanlapakorn, Sompong Vongpunsawad, Yong Poovorawan
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971222005793
_version_ 1797980831772311552
author Siripat Pasittungkul
Ilada Thongpan
Preeyaporn Vichaiwattana
Thanunrat Thongmee
Sirapa Klinfueng
Nungruthai Suntronwong
Nasamon Wanlapakorn
Sompong Vongpunsawad
Yong Poovorawan
author_facet Siripat Pasittungkul
Ilada Thongpan
Preeyaporn Vichaiwattana
Thanunrat Thongmee
Sirapa Klinfueng
Nungruthai Suntronwong
Nasamon Wanlapakorn
Sompong Vongpunsawad
Yong Poovorawan
author_sort Siripat Pasittungkul
collection DOAJ
description Objectives: To investigate the seroprevalence of respiratory syncytial virus (RSV) infections in young children, the correlation between RSV antibody levels in maternal and cord serum, and to provide evidence of RSV reinfection in Thai children after primary infections. Methods: Serum samples were collected from 302 mothers and 291 children between 2015 and 2021. Maternal and cord blood were collected at birth. Serial serum samples of children were collected at the ages of 2, 7, 18, 19, 24, 36, 48, and 60 months and the presence of anti-RSV immunoglobulin G (IgG) was tested using an enzyme-linked immunosorbent assay. Results: The cord: maternal serum antibody ratio was 1.09 (95% confidence interval 1.08-1.11). Although >90% of babies at birth were seropositive through transplacental transfer, antibody levels gradually declined, with the highest seronegative rate (91.9%) at 7 months of age. Subsequently, anti-RSV IgG levels increased with age, most likely due to natural infection. One-third of the children showed evidence of reinfection as determined by seroconversion of anti-RSV IgG or increased titers of at least 50 relative units/ml. Conclusion: Waning of RSV antibodies in infants is rapid, and RSV infection subsequently increases anti-RSV IgG titers. RSV vaccination in children before the age of 7 months should be recommended.
first_indexed 2024-04-11T06:01:09Z
format Article
id doaj.art-a7a1157c10fe48409f3d59fa994a6719
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-04-11T06:01:09Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-a7a1157c10fe48409f3d59fa994a67192022-12-22T04:41:42ZengElsevierInternational Journal of Infectious Diseases1201-97122022-12-01125177183High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in ThailandSiripat Pasittungkul0Ilada Thongpan1Preeyaporn Vichaiwattana2Thanunrat Thongmee3Sirapa Klinfueng4Nungruthai Suntronwong5Nasamon Wanlapakorn6Sompong Vongpunsawad7Yong Poovorawan8Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, USACenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Corresponding author: Yong Poovorawan, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.Objectives: To investigate the seroprevalence of respiratory syncytial virus (RSV) infections in young children, the correlation between RSV antibody levels in maternal and cord serum, and to provide evidence of RSV reinfection in Thai children after primary infections. Methods: Serum samples were collected from 302 mothers and 291 children between 2015 and 2021. Maternal and cord blood were collected at birth. Serial serum samples of children were collected at the ages of 2, 7, 18, 19, 24, 36, 48, and 60 months and the presence of anti-RSV immunoglobulin G (IgG) was tested using an enzyme-linked immunosorbent assay. Results: The cord: maternal serum antibody ratio was 1.09 (95% confidence interval 1.08-1.11). Although >90% of babies at birth were seropositive through transplacental transfer, antibody levels gradually declined, with the highest seronegative rate (91.9%) at 7 months of age. Subsequently, anti-RSV IgG levels increased with age, most likely due to natural infection. One-third of the children showed evidence of reinfection as determined by seroconversion of anti-RSV IgG or increased titers of at least 50 relative units/ml. Conclusion: Waning of RSV antibodies in infants is rapid, and RSV infection subsequently increases anti-RSV IgG titers. RSV vaccination in children before the age of 7 months should be recommended.http://www.sciencedirect.com/science/article/pii/S1201971222005793SeroprevalenceRSVReinfectionInfantsYoung children
spellingShingle Siripat Pasittungkul
Ilada Thongpan
Preeyaporn Vichaiwattana
Thanunrat Thongmee
Sirapa Klinfueng
Nungruthai Suntronwong
Nasamon Wanlapakorn
Sompong Vongpunsawad
Yong Poovorawan
High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
International Journal of Infectious Diseases
Seroprevalence
RSV
Reinfection
Infants
Young children
title High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
title_full High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
title_fullStr High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
title_full_unstemmed High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
title_short High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
title_sort high seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in thailand
topic Seroprevalence
RSV
Reinfection
Infants
Young children
url http://www.sciencedirect.com/science/article/pii/S1201971222005793
work_keys_str_mv AT siripatpasittungkul highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand
AT iladathongpan highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand
AT preeyapornvichaiwattana highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand
AT thanunratthongmee highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand
AT sirapaklinfueng highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand
AT nungruthaisuntronwong highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand
AT nasamonwanlapakorn highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand
AT sompongvongpunsawad highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand
AT yongpoovorawan highseroprevalenceofantibodiesagainsthumanrespiratorysyncytialvirusandevidenceofrespiratorysyncytialvirusreinfectioninyoungchildreninthailand